Stockscreener 앱 받기
1.2519
2.27%
-0.0281
전일 마감가:
$1.28
열려 있는:
$1.28
하루 거래량:
117.50K
Relative Volume:
0.04
시가총액:
$43.04M
수익:
-
순이익/손실:
$-16.14M
주가수익비율:
-2.3183
EPS:
-0.54
순현금흐름:
$-3.99M
1주 성능:
-10.65%
1개월 성능:
-16.61%
6개월 성능:
-40.43%
1년 성능:
-70.50%
1일 변동 폭
$1.25
$1.29
1주일 범위
$1.23
$1.47
52주 변동 폭
$1.12
$7.0791
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
명칭
Telomir Pharmaceuticals Inc
전화
786-396-6723
주소
100 SE 2ND ST, MIAMI
TELO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
1.2518 | 44.01M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
428.99 | 108.28B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.98 | 79.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
440.19 | 57.65B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.78 | 56.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
202.28 | 42.39B | 447.02M | -1.18B | -906.14M | -6.1812 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-21 | 개시 | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc 주식(TELO)의 최신 뉴스
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Telomir Pharmaceuticals Bounce Back? - StocksToTrade
Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025 - ts2.tech
Telomir stock surges after leukemia cell-killing data By Investing.com - Investing.com Nigeria
Telomir stock surges after leukemia cell-killing data - Investing.com
Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells - ACCESS Newswire
Telomir Pharma (NASDAQ: TELO) Telomir-1 Shows Preclinical HL60 Leukemia Activity - Stock Titan
TELO Stock Jumps Pre-market After Early Study Results Show Leukemia Cell Death - Stocktwits
Telomir Pharmaceuticals director Craig Eagle resigns from board By Investing.com - Investing.com Australia
Telomir Pharmaceuticals director Craig Eagle resigns from board - Investing.com
Telomir Pharmaceuticals’ Telomir-1 Shows Leukemia Efficacy - TipRanks
How Telomir Pharmaceuticals Inc. stock performs after earnings2025 Market Overview & Precise Buy Zone Tips - newser.com
Does Telomir Pharmaceuticals Inc. stock trade at a discount to peersQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
Will Telomir Pharmaceuticals Inc. bounce back from current supportMarket Activity Recap & Precise Buy Zone Tips - newser.com
Has Telomir Pharmaceuticals Inc. found a price floorJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com
Telomir Pharmaceuticals Completes $2.9 Million Stock Sale - MSN
Analyzing Telomir Pharmaceuticals Inc. with risk reward ratio charts2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com
What technical models suggest about Telomir Pharmaceuticals Inc.’s comebackFed Meeting & Daily Oversold Bounce Ideas - newser.com
What’s the recovery path for long term holders of Telomir Pharmaceuticals Inc.Sell Signal & High Win Rate Trade Tips - newser.com
Will Telomir Pharmaceuticals Inc. rebound enough to break even2025 Retail Activity & Reliable Trade Execution Plans - newser.com
What Institutional Trends Suggest About Harshdeep Hortico Limiteds DirectionStock Watchlist Updates & Explosive Capital Growth - earlytimes.in
Is Telomir Pharmaceuticals Inc a good long term investmentCandlestick Pattern Analysis & Budget Friendly Portfolio - earlytimes.in
How Telomir Pharmaceuticals Inc. stock reacts to global recession fearsMarket Activity Recap & Free Fast Gain Swing Trade Alerts - newser.com
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line - The Florida Times-Union
Sentiment analysis tools applied to Telomir Pharmaceuticals Inc.2025 Dividend Review & Reliable Breakout Stock Forecasts - newser.com
Momentum divergence signals in Telomir Pharmaceuticals Inc. chartJuly 2025 PostEarnings & Weekly Top Gainers Trade List - newser.com
Telomir Pharmaceuticals Inc (TELO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.13%
1.71%
자본화:
|
볼륨(24시간):